.Publisheru00e2 $ s note Springer Attributes remains neutral with regard to administrative claims in...
.Study layout, clinical cohort and principles statementThe DoxyPEP trial (ClinicalTrials.gov registr...
.Attribute Medication, Released online: 30 September 2024 doi:10.1038/ d41591-024-00071-9Daily shot ...
.Attribute Medicine, Posted online: 30 September 2024 doi:10.1038/ s41591-024-03242-wFDA advising bo...
.Attribute Medication, Published online: 01 Oct 2024 doi:10.1038/ s41591-024-03289-9Artificial notic...
.Ethics statementEVER-132-002 was compliant with Announcement of Helsinki and International Council ...
.Ethics claim inclusion and ethicsThe 100K GP is actually a UK course to examine the market value of...
.Trial design and participantsBARACK-D was a PROBE trial34. The test layout and also rationale for t...
.General approachWe proceeded in 3 steps. Initially, our experts projected ageu00e2 $ "causeu00e2 $ ...
.Team of Professional Contamination, Microbiology & Immunology, Principle of Contamination, Vet a...
.Publisheru00e2 $ s keep in mind Springer Structure stays neutral for jurisdictional cases in posted...
.Attributes Medicine, Published online: 23 September 2024 doi:10.1038/ s41591-024-03272-4As medical ...
.Contending enthusiasms.S.K.: Sell as well as Other Possession Enthusiasms: Iylon, Lutris, Molecular...
.Publisheru00e2 $ s keep in mind Springer Nature stays neutral for jurisdictional cases in released ...
.RESEARCH EMPHASIZE.19 September 2024.
Plozasiran lowered triglyceride degrees through 80% as wel...
.OPT-PACE tested whether a screening test, in this case an echocardiogram to determine LVSD, in indi...